Morgan Stanley Maintains Equal-Weight on Accolade, Lowers Price Target to $6
Accolade +5.96% Pre
Accolade ACCD | 3.38 3.38 | +5.96% 0.00% Pre |
Morgan Stanley analyst Ricky Goldwasser maintains Accolade (NASDAQ:
ACCD) with a Equal-Weight and lowers the price target from $12 to $6.